Correlation Between Concord Securities and BRIM Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Concord Securities and BRIM Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Concord Securities and BRIM Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Concord Securities Co and BRIM Biotechnology, you can compare the effects of market volatilities on Concord Securities and BRIM Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Concord Securities with a short position of BRIM Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Concord Securities and BRIM Biotechnology.

Diversification Opportunities for Concord Securities and BRIM Biotechnology

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between Concord and BRIM is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Concord Securities Co and BRIM Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRIM Biotechnology and Concord Securities is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Concord Securities Co are associated (or correlated) with BRIM Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRIM Biotechnology has no effect on the direction of Concord Securities i.e., Concord Securities and BRIM Biotechnology go up and down completely randomly.

Pair Corralation between Concord Securities and BRIM Biotechnology

Assuming the 90 days trading horizon Concord Securities Co is expected to generate 0.37 times more return on investment than BRIM Biotechnology. However, Concord Securities Co is 2.68 times less risky than BRIM Biotechnology. It trades about -0.03 of its potential returns per unit of risk. BRIM Biotechnology is currently generating about -0.08 per unit of risk. If you would invest  1,370  in Concord Securities Co on September 2, 2024 and sell it today you would lose (5.00) from holding Concord Securities Co or give up 0.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Concord Securities Co  vs.  BRIM Biotechnology

 Performance 
       Timeline  
Concord Securities 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Concord Securities Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Concord Securities is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
BRIM Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Concord Securities and BRIM Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Concord Securities and BRIM Biotechnology

The main advantage of trading using opposite Concord Securities and BRIM Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Concord Securities position performs unexpectedly, BRIM Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRIM Biotechnology will offset losses from the drop in BRIM Biotechnology's long position.
The idea behind Concord Securities Co and BRIM Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges